Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Episodes 65-80 of 137
- Project Oncology®
A Look at What’s New in Invasive Lobular Carcinoma
Pavani Chalasani, MD, MPH
Jason A. Mouabbi, MD
- Project Oncology®
The Role of PARP Inhibitors in Metastatic Breast Cancer
- Project Oncology®
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Jacob Sands, MD
Jia Luo, MD
- Project Oncology®
Diving into the Efficacy & Tolerability of mBC Treatment
Pavani Chalasani, MD, MPH
Colleen Bohnenkamp, PharmD, BCPS, BCOP
- Project Oncology®
Reducing the Rise of Uterine Cancer in the United States
Charles Turck, PharmD, BCPS, BCCCP
Richard T. Penson, MD, MRCP
- Project Oncology®
Investigating a Therapy for Brain Metastases: A Growing Problem
Charles Turck, PharmD, BCPS, BCCCP
Priscilla Brastianos, MD
- Project Oncology®
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Vivek Subbiah, MD
- Project Oncology®
Impact of Infertility & Elective Fertility Among Female Oncologists
Emily MacDuffie, MD
- Project Oncology®
Combating the Complexities of Cancer Care During Pregnancy
Alison Wakoff Loren, MD, MSCE
Jacob Sands, MD
Joseph O. Jacobson, MD
- Project Oncology®
Managing Immunotherapy Toxicities in Lung Cancer Patients
Jacob Sands, MD
Aliyah Pabani, MD
- Project Oncology®
Exploring the Role of Biomarkers in Lung Cancer Treatment
Jacob Sands, MD
Biagio Ricciuti, MD
- Project Oncology®
Recognizing the Role of Capmatinib for METex14 in NSCLC
Jacob Sands, MD
Edward B. Garon, MD, MS
- Project Oncology®
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Pavani Chalasani, MD, MPH
Erika Hamilton, MD